Sen. Larry Cramer's (R-N.D.) amendment apparently might have required all covered entities, not just health centers, to pass along 340B savings to patients on insulin, injectable epinephrine, or other products. | Source: C-SPAN

Failed Amendment to Federal Budget Bill Could Have Required All Providers to Pass 340B Savings on Insulin to Patients

A second Republican 340B-related amendment, regarding what covered entities could charge patients for insulin, was offered and then tabled in the U.S. Senate late last week to a budget bill linked to Democrats’ forthcoming COVID-19 relief package.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content